Biol Reprod Keystone Symposia Conference on Frontiers in Reproductive Biology & Regulation of Fertility.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


BOR - Papers in Press, published online ahead of print April 7, 2004.
Biol Reprod 2004, 10.1095/biolreprod.103.025197
This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
71/2/620    most recent
biolreprod.103.025197v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Warnes, K. E.
Right arrow Articles by Coulter, C. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Warnes, K. E.
Right arrow Articles by Coulter, C. L.
Agricola
Right arrow Articles by Warnes, K. E.
Right arrow Articles by Coulter, C. L.
Submitted November 5, 2003
Returned for revision November 28, 2003
Accepted March 30, 2004

Mechanisms of Hormone Action


Differential Actions of Metyrapone on the Fetal Pituitary-Adrenal Axis in the Sheep Fetus in Late Gestation

K. E. Warnes , I. C. McMillen , J. S. Robinson , and C. L. Coulter *

* To whom correspondence should be addressed. E-mail: catherine.coulter{at}adelaide.edu.au.

Abstract
It is not clear if an increase in intra-adrenal cortisol is required to mediate the actions of ACTH on adrenal growth and steroidogenesis during the prepartum stimulation of the fetal pituitary-adrenal axis. We infused metyrapone, a competitive inhibitor of cortisol biosynthesis into fetal sheep between 125 and 140 days gestation (term = 147 ± 3 d) and measured fetal plasma cortisol, 11-desoxycortisol, and ACTH, pituitary pro-opiomelanocortin (POMC) mRNA and expression of ACTH receptor (melanocortin type 2 receptor; MC2-R), steroidogenic acute regulatory protein (StAR), 11 beta hydroxysteroid dehydrogenase type 2 (11{beta}HSD2), cytochrome P450 cholesterol side chain cleavage (CYP11A1), cytochrome P450 17 hydroxylase (CYP17), 3{beta} hydroxysteroid dehydrogenase (3{beta}HSD) and cytochrome P450 21 hydroxylase (CYP21A1) mRNA and StAR protein in the fetal adrenal gland. Plasma ACTH and 11-desoxycortisol concentrations were higher (P<0.05), whilst plasma cortisol concentrations were not significantly different in metyrapone compared with vehicle infused fetuses. The ratio of plasma cortisol: ACTH concentrations was higher (P<0.0001), between 136-140d than between 120-135d gestation in both metyrapone and vehicle-infused fetuses. The combined adrenal weight and adrenocortical thickness were greater (P<0.001) and cell density was lower (P<0.01) in the zona fasciculata of adrenals from the metyrapone infused group. Adrenal StAR mRNA expression was lower (P<0.05), whilst the levels of mature StAR protein (30 kDa) were higher (P<0.05) in the metyrapone infused fetuses. In addition, adrenal mRNA expression of 11{beta}HSD2, CYP11A1 and CYP17 were higher (P<0.05) in the metyrapone infused fetuses. Thus metyrapone administration may represent a unique model which allows the dissociation of the relative actions of ACTH and cortisol on fetal adrenal steroidogenesis and growth during late gestation to be investigated.

Key words: Pregnancy • Adrenal cortex • Adrenocorticotropic hormone receptor • Anterior pituitary • Steroid hormones





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2004 by the Society for the Study of Reproduction.